Registered entities
Lassen Therapeutics 1, Inc.
Reg. No. 83-2152126United States
Innovation
6 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 579 times.
| Year | Filings |
|---|---|
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 3 |
Investor mix
8 investors on record; lead investors include Frazier Healthcare Partners, Longitude Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 63% |
| Private equity | 3 | 38% |